John Oyler, BeiGene CEO (Paul Yeung/Bloomberg via Getty Images)
BeiGene will rebrand to BeOne Medicines, dropping name's link to China roots
The global pharma company whose name rhymes with the capital of China wants people to know that it is not in fact a Chinese company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
